| Unique ID issued by UMIN | UMIN000063648 |
|---|---|
| Receipt number | R000071076 |
| Scientific Title | Activity Pacing-Based Coaching Through Notifications to Enhance Self-Efficacy in Cancer Survivors |
| Date of disclosure of the study information | 2026/11/16 |
| Last modified on | 2026/11/16 17:37:59 |
A pilot study of AI chatbot notifications to support confidence in being physically active among breast and gynecological cancer survivors
ACT
Activity Pacing-Based Coaching Through Notifications to Enhance Self-Efficacy in Cancer Survivors
ACT
| Japan |
Breast and gynecological cancer survivors
| Not applicable |
Malignancy
NO
To preliminarily evaluate whether morning notifications prompting exercise goal setting and evening notifications prompting achievement reporting improve exercise and physical activity self-efficacy compared with no notifications, using a behavioral science-based AI chatbot on LINE for activity pacing support in breast and gynecological cancer survivors. Secondary objectives are to explore behavioral changes, physical activity, cancer-related fatigue, and usability. The same AI chatbot is available in both periods; the study evaluates the added effect of scheduled notifications for behavior change support.
Efficacy
Exploratory
Not applicable
Exercise and physical activity self-efficacy, assessed using two items with four response categories developed based on a health checkup questionnaire, on Days 1, 15, 29, and 43. Change in period 1 is Day 15 minus Day 1, and change in period 2 is Day 43 minus Day 29. The difference in change between the notification and no-notification periods will be estimated with equal weighting of the two allocation sequences, with a 95% confidence interval.
1) Self-reported exercise goals and goal achievement during the notification period.
2) Physical activity: Global Physical Activity Questionnaire (GPAQ, 16 items), Days 1, 15, 29, and 43.
3) Cancer-related fatigue: Cancer Fatigue Scale (15 items), Days 1, 15, 29, and 43.
4) Stage of behavior change (one item), Days 1, 15, 29, and 43.
5) Usability: UMUX-LITE (two items, seven-point response scale), Days 15 and 43.
6) LINE chat text and timestamped usage logs throughout study participation.
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
No treatment
2
Educational,Counseling,Training
| Behavior,custom |
Sequence A (notifications first; target n=50): On Days 1-14, participants use a behavioral science-based AI chatbot on LINE. A daily 07:00 notification proposes one exercise goal and prompts goal setting; a daily 20:00 notification prompts achievement reporting. Notification times are adjustable by up to one hour in 30-minute increments. Days 15-28 constitute a 14-day washout period. On Days 29-42, the no-notification condition uses the same chatbot, responding only to participant-initiated messages. Both conditions use the same AI chatbot and provide access to exercise videos. Behavior change support uses goal setting, self-monitoring, feedback, and encouragement. The AI does not provide diagnosis, treatment decisions, or medical exercise prescriptions. Questionnaires are administered on Days 1, 15, 29, and 43. Participation is through Day 43, up to 48 days including the final questionnaire deadline.
Sequence B (no notifications first; target n=50): On Days 1-14, the no-notification condition uses the same AI chatbot on LINE, responding only to participant-initiated messages. Days 15-28 constitute a 14-day washout period. On Days 29-42, daily notifications are provided at 07:00 to propose one exercise goal and prompt goal setting, and at 20:00 to prompt achievement reporting. Notification times are adjustable by up to one hour in 30-minute increments. Both conditions use the same AI chatbot and provide access to exercise videos. Behavior change support uses goal setting, self-monitoring, feedback, and encouragement. The AI does not provide diagnosis, treatment decisions, or medical exercise prescriptions. Questionnaires are administered on Days 1, 15, 29, and 43. Participation is through Day 43, up to 48 days including the final questionnaire deadline.
| 18 | years-old | <= |
| Not applicable |
Female
Participants must meet all of the following criteria:
1) Provide electronic informed consent.
2) Female and aged 18 years or older at consent.
3) Have a self-reported diagnosis of breast or gynecological cancer.
4) Own a smartphone, be able to use LINE, and be able to enable notifications.
5) Be able to continue participation for up to 48 days, including the final questionnaire response deadline.
Any of the following:
1) Physician-imposed exercise restrictions because of bone metastases, severe heart disease, or another condition contraindicating exercise.
2) PHQ-2 total score of 3 or higher.
3) Pain interference with daily activities rated as quite a bit or very much on the PRO-CTCAE.
4) Currently prescribed exercise therapy.
100
| 1st name | Akiko |
| Middle name | |
| Last name | Hanai |
Chiba University
Faculty of Informatics
263-8522
1-33 Yayoi-cho, Inage-ku, Chiba, Chiba, Japan
043-290-2708
akiko.hanai@chiba-u.jp
| 1st name | Akiko |
| Middle name | |
| Last name | Hanai |
Chiba University
Faculty of Informatics
263-8522
1-33 Yayoi-cho, Inage-ku, Chiba, Chiba, Japan
043-290-2708
akiko.hanai@chiba-u.jp
Japan Institute for Health Security
Yoichi Shimizu
Ministry of Education, Culture, Sports, Science and Technology / Japan Society for the Promotion of Science (JSPS KAKENHI JP24K22219)
Japanese Governmental office
Japan
Faculty of Informatics, Chiba University; Institute for Cancer Control, National Cancer Center Japan; Faculty of Nursing, Iwate Prefectural University
SECOM Science and Technology Foundation (Challenging Research Grant; principal investigator: Akiko Hanai)
Ethics Review Committee, Japan Institute for Health Security
1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
03-3202-7181
kenkyu-shinsa@jihs.go.jp
NO
千葉大学(千葉県)、国立健康危機管理研究機構 国立看護大学校(東京都)、国立がん研究センター(東京都)、岩手県立大学(岩手県)
| 2026 | Year | 11 | Month | 16 | Day |
Unpublished
The study protocol does not specify a plan to share individual participant data outside the research team.
Data provided to participating research institutions and authorized analysts are limited to analysis datasets from which direct identifiers have been removed. Linkage keys and administrative data will not be provided. Any use for a new research purpose beyond the present study requires the necessary ethics review and related procedures.
Open public recruiting
| 2026 | Year | 08 | Month | 18 | Day |
| 2026 | Year | 10 | Month | 15 | Day |
| 2026 | Year | 11 | Month | 05 | Day |
| 2027 | Year | 01 | Month | 03 | Day |
| 2026 | Year | 11 | Month | 16 | Day |
| 2026 | Year | 11 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071076